Lingxian Qiu

Xiamen University — China

Medicine · Health Sciences

7h-index203citations15works2.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cervical Cancer and HPV Research(5), Hepatitis B Virus Studies(5), Herpesvirus Infections and Treatments(5), Genital Health and Disease(3), Poxvirus research and outbreaks(3)

Publications15 total

The nasopharyngeal carcinoma in Xiamen China from 2011 to 2020: a population-based linkage study
BMC Cancer·2025Open Access
Immunogenicity comparison of an Escherichia coli-produced 9-valent human papillomavirus vaccine and Gardasil9 in Chinese women aged 18–26 years: three-year follow-up data from a randomised clinical trial
The Lancet Regional Health - Western Pacific·2025· 2 citedOpen Access
Long-term efficacy and immunopersistence of an Escherichia coli-produced HPV-16/18 bivalent vaccine: an observational extension study following a randomised, double-blind Phase III clinical trial cohort
The Lancet Regional Health - Western Pacific·2025· 1 citedOpen Access
The incidence, mortality, and survival rate of colorectal cancer in Xiamen, China, from 2011 to 2020
BMC Public Health·2025· 1 citedOpen Access
The variations in the natural history of high‐risk <scp>human papillomavirus</scp> infections in Chinese healthy women aged 27–45 years compared with 18–26 years: A prospective cohort study
International Journal of Cancer·2024· 4 cited
Immunogenicity and safety of an ORF7-deficient skin-attenuated and neuro-attenuated live vaccine for varicella: a randomised, double-blind, controlled, phase 2a trial
The Lancet Infectious Diseases·2024· 4 cited
The epidemiology of varicella and effectiveness of varicella vaccine in Ganyu, China: a long-term community surveillance study
BMC Public Health·2023· 13 citedOpen Access
Safety and immunogenicity of a skin- and neuro-attenuated live vaccine for varicella: a randomized, double-blind, controlled, dose-escalation and age de-escalation phase 1 clinical trial
The Lancet Regional Health - Western Pacific·2023· 5 citedOpen Access
Prognosis of hepatitis E infection in patients with chronic liver disease: A meta‐analysis
Journal of Viral Hepatitis·2022· 36 cited
Awareness and acceptance of HPV vaccination for condyloma acuminata among men who have sex with men in China
Human Vaccines & Immunotherapeutics·2022· 9 citedOpen Access
Risk of hepatocellular carcinoma in antiviral treatment-naïve chronic hepatitis B patients treated with entecavir or tenofovir disoproxil fumarate: a network meta-analysis
BMC Cancer·2022· 37 citedOpen Access
Inflammation-related adverse reactions following vaccination potentially indicate a stronger immune response
Emerging Microbes & Infections·2021· 55 citedOpen Access
Maternal CMV seroprevalence rate in early gestation and congenital cytomegalovirus infection in a Chinese population
Emerging Microbes & Infections·2021· 24 citedOpen Access
Progress in clinical research of varicella vaccines
Zhonghua weishengwuxue he mianyixue zazhi·2019· 1 cited
Prevalence, Concordance, and Transmission of Human Papillomavirus Infection Among Heterosexual Couples in Liuzhou, China: An Observational Perspective Study
The Journal of Infectious Diseases·2019· 11 cited

Frequent Co-authors

Jun Zhang(11), Yingying Su(10), Ting Wu(10), Ningshao Xia(10), Shoujie Huang(9), Yue Huang(7), Jiali Quan(7), Zhaofeng Bi(6), Guo‐Hua Zhong(4), Kongxin Zhu(4), Chunlan Zhuang(3), You‐Lin Qiao(3), Xingmei Yao(3), Minglei Zhang(3), Jin‐Bo Xu(3), Wei Wang(3), Guohua Zhong(3), Tong Cheng(3), Fangfang Hu(2), Xiaohui Liu(2)